Clinical Trials Directory

Effect of Ondansetron for Withdrawal Symptoms

We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has shown anecdotal evidence of being affective for the treatment of withdrawal symptoms and we hope to determine whether this is affective.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • drug : Ondansetron and Placebo crossover

Phase: N/A


Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

-Over 18 years of age - No medical contraindications to medication - Able to fulfill research procedures

External Links

Contact information

Primary Contact:

Rebecca McCue 6507240522

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: